Тендеры России
Поиск
A Pembrolizumab (Genetical Recombination) IV Infusion 100 mg set of 1 vial: approx. 766 sets B Daratumumab (Genetical Recombination) Vorhyaluronidase Alfa (Genetical Recombination) Combination SC injection set of 1vial: approx. 305 sets C Ravulizu... (Япония - Тендер #69998183) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Япония (другие тендеры и закупки Япония) Организатор тендера: Procurement Notices of Japanese Local Government Номер конкурса: 69998183 Дата публикации: 16-01-2026 Источник тендера: Procurement Notices of Japanese Local Government |
||
| Publishing date | Jan 15, 2026 |
|---|---|
| Procurement entity | Sapporo City(Hokkaido) |
| Classification | 0004 Medical & Pharmaceutical Products |
| Summary of notice |
Summary (1) Nature and the quantity of the products to be procured A Pembrolizumab (Genetical Recombination) IV Infusion 100 mg set of 1 vial: approx. 766 sets B Daratumumab (Genetical Recombination) Vorhyaluronidase Alfa (Genetical Recombination) Combination SC injection set of 1vial: approx. 305 sets C Ravulizumab (Genetical Recombination) IV Infusion 300 mg/3mL set of 1 vial: approx. 173 sets D Epcoritamab (Genetical Recombination) SC injection 48 mg set of 1 vial: approx. 51 sets E Atezolizumab (Genetical Recombination) IV Infusion 1200 mg/20mL set of 1 vial: approx. 131 sets F Nivolumab (Genetical Recombination) kit for IV Infusion 240 mg set of 1vial: approx. 206 sets G Elranatamab (Genetical Recombination) SC injection 76 mg/1.9mL set of 1 vial: approx. 60 sets H Aflibercept (Genetical Recombination) 2 mg IVT injection 40 mg/mL set of 1 kit: approx. 495 sets I Aflibercept (Genetical Recombination) 8 mg IVT injection 114.3 mg/mL set of 1 kit: approx. 381 sets J Durvalumab (Genetical Recombination) IV Infusion 500 mg/10mL set of 1 vial: approx. 191 sets K Teprotumumab (Genetical Recombination) IV infusion 500 mg set of 1 vial: approx. 51 sets L Lenalidomide Hydrate Capsules 5 mg set of 40 capsules: approx. 147 sets M Risankizumab (Genetical Recombination) SC 150 mg pen 1 mL set of 1 pen: approx. 97 sets N Emicizumab (Genetical Recombination) SC injection 105 mg/0.7mL set of 1 vial: approx. 45 sets O Canakinumab (Genetical Recombination) SC injection 150 mg set of 1 vial: approx. 25 sets (2) Time limit for tender: 17:00 on February 18 (Wed.), 2026 (3) Contact point for the notice: Management & Planning Section, Management Department, Management Office, Hospital Bureau, Sapporo Municipal Government, Kita 11-jo Nishi 13- chome, Chuo-ku, Sapporo 060-8604, Japan. TEL 011-726-2211 |